[HTML][HTML] Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis

BJ Langford, M So, M Simeonova, V Leung, J Lo… - The Lancet …, 2023 - thelancet.com
Background Frequent use of antibiotics in patients with COVID-19 threatens to exacerbate
antimicrobial resistance. We aimed to establish the prevalence and predictors of bacterial …

Pathogenesis of respiratory viral and fungal coinfections

F Salazar, E Bignell, GD Brown, PC Cook… - Clinical Microbiology …, 2022 - Am Soc Microbiol
Individuals suffering from severe viral respiratory tract infections have recently emerged as
“at risk” groups for developing invasive fungal infections. Influenza virus is one of the most …

[HTML][HTML] Risk factors for fungal co-infections in critically ill COVID-19 patients, with a focus on immunosuppressants

OT Ezeokoli, O Gcilitshana, CH Pohl - Journal of Fungi, 2021 - mdpi.com
Severe cases of coronavirus disease 2019 (COVID-19) managed in the intensive care unit
are prone to complications, including secondary infections with opportunistic fungal …

[HTML][HTML] Corticosteroids for COVID-19: worth it or not?

F Akter, Y Araf, MJ Hosen - Molecular Biology Reports, 2022 - Springer
Pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induced
COVID-19 implied the presence of excessive proinflammatory cytokines and chemokines in …

Effect of corticosteroid therapy on mortality in COVID‐19 patients—A systematic review and meta‐analysis

C Patel, K Parmar, D Patel, S Patel… - Reviews in Medical …, 2022 - Wiley Online Library
The effect of corticosteroid therapy is still controversial on prevention of mortality in
coronavirus disease‐2019 (COVID‐19). The objective of this study is to investigate the effect …

[HTML][HTML] Improved outcomes over time for adult COVID-19 patients with acute respiratory distress syndrome or acute respiratory failure

EO Yeates, J Nahmias, J Chinn, B Sullivan… - PLoS …, 2021 - journals.plos.org
Background COVID-19's pulmonary manifestations are broad, ranging from pneumonia with
no supplemental oxygen requirements to acute respiratory distress syndrome (ARDS) with …

[HTML][HTML] Fungal infections in the ICU during the COVID-19 pandemic in Mexico

CM Roman-Montes, S Bojorges-Aguilar… - Journal of Fungi, 2023 - mdpi.com
Background: Invasive Fungal Infections (IFI) are emergent complications of COVID-19. In
this study, we aim to describe the prevalence, related factors, and outcomes of IFI in critical …

[HTML][HTML] Fungal infections in critically ill COVID-19 patients: Inevitabile malum

N Rovina, E Koukaki, V Romanou, S Ampelioti… - Journal of Clinical …, 2022 - mdpi.com
Patients with severe COVID-19 belong to a population at high risk of invasive fungal
infections (IFIs), with a reported incidence of IFIs in critically ill COVID-19 patients ranging …

A close‐up view of dynamic biomarkers in the setting of COVID‐19: Striking focus on cardiovascular system

A Rezabakhsh, SR Sadat‐Ebrahimi… - Journal of Cellular …, 2022 - Wiley Online Library
Based on the recent reports, cardiovascular events encompass a large portion of the
mortality caused by the COVID‐19 pandemic, which drawn cardiologists into the …

[HTML][HTML] Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence

R Sarzani, F Spannella, F Giulietti, C Di Pentima… - Internal and Emergency …, 2022 - Springer
Since the publication of the RECOVERY trial, the use of glucocorticoid drugs (GC) has
spread for the treatment of severe COVID-19 worldwide. However, the benefit of …